Actozymes Capsules
Natural health product licensed in Canada
- Licence holder
- Accurex Health Care Manufacturing Inc.
- NPN or DIN-HM
- 80039056
- Status
- Active licence
- Licence date
- 23 January 2013
- Revision date
- 15 June 2013
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3-(O-6-désoxy-alpha-l-mannopyranosyl-(1-6)-bêta-d-glucopyranosyloxy)-2-(3,4-dihydroxyphényl)-5,7-dihydroxy-4H-chromen-4-one Source : Styphnolobium japonicum - fleur | 100 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 2,000.6 FCC DU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 45.6 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger | 100.2 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger | 8.2 mg | Not calculated |
| Chymotrypsine Source : Sus scrofa - pancréas | 83.25 Unité de chymotrypsine de la USP | Not calculated |
| Chymotrypsine Source : Sus scrofa - pancréas | 3.33 mg | Not calculated |
| Bromélaïne de tige Source : Pineapple stem | 30,000 FCC PU | Not calculated |
| Bromélaïne de tige Source : Pineapple stem | 3.33 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 5,000 FCC HUT | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 45 mg | Not calculated |
| Trypsine Source : Sus scrofa - pancréas | 96 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée, Gélatine, Calcium phosphate dibasic, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive Aid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80039056
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2013. Photograph the packaging to check whether it has changed. Photograph the packaging